Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

BridgeBio Pharma Stock Price, Quotes and Forecasts | NASDAQ:BBIO | Benzinga

Q: What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore BridgeBio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBIO.

Open	$34.50
Close	-
Volume / Avg.	397.36K / 3.22M
Day Range	$33.58 - $34.61
52 Wk Range	21.62 - 39.47
Market Cap	$6.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	17.46%
Days to Cover	9.01

Recent News

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to market it.

Vandana Singh

Top 4 Health Care Stocks You May Want To Dump In Q1

Avi Kapoor

Gold Down Over 3%; Rigetti Computing Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$34.50
Close	-
Volume / Avg.	397.36K / 3.22M
Day Range	$33.58 - $34.61
52 Wk Range	21.62 - 39.47
Market Cap	$6.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	17.46%
Days to Cover	9.01

About BridgeBio Pharma Inc

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and deliver...

Got Questions? Ask

Compare BBIO performance to the market?

How is the earnings season affecting BBIO?

What is BBIO's debt-to-equity ratio?

What is BBIO's operating cash flow?

What’s driving BBIO's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BridgeBio Pharma (BBIO) stock?

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Who are BridgeBio Pharma (BBIO) competitors?

Other companies in BridgeBio Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

BridgeBio Pharma has a consensus price target of $46.53.

What is the current price for BridgeBio Pharma (BBIO)?

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $33.925 last updated April 14, 2025 at 12:01 PM EDT.

Does BridgeBio Pharma (BBIO) pay a dividend?

There are no upcoming dividends for BridgeBio Pharma.

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

BridgeBio Pharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is BridgeBio Pharma (BBIO) going to split?

There is no upcoming split for BridgeBio Pharma.

What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BridgeBio Pharma Stock Price, Quotes and Forecasts

BridgeBio Pharma (BBIO) Forecast